Antitrust

February 6, 2018 Merck & Co., Inc., Glenmark Pharmaceuticals, Ltd., and several of their respective subsidiaries are facing a lawsuit that claims the parties unlawfully delayed the launch of generic alternatives to Merck’s brand name high cholesterol drug, Zetia.

February 2, 2018 A group of 15 manufacturers has been accused of colluding to fix the prices of inductors, causing consumers to pay more than they would have in a competitive market.

February 2, 2018 CDK Global and the Reynolds and Reynolds Company face a second antitrust class action claiming they fixed prices for car dealerships' data management.

January 26, 2018 Three operating companies of the Jimmy John’s sandwich restaurant franchise have been named as defendants in a proposed class action lawsuit that alleges the parties unlawfully instructed franchisees not to hire each other’s employees.

January 26, 2018 A proposed class action lawsuit has been filed against a group of electronics manufacturers over claims that the defendants have colluded to fix the price of inductors.

January 17, 2018 Allergan, Inc. has faced a series of lawsuits alleging it unlawfully delayed the entrance to the market of generic alternatives to its cyclosporine ophthalmic emulsion drug, Restasis, causing consumers to be overcharged for the medicine.

January 11, 2018 A proposed class action has been filed in California federal court against Allergan, Inc., claiming the drug manufacturer attempted to delay the entrance of generic alternatives to its cyclosporine ophthalmic emulsion drug, Restasis.

January 11, 2018 A proposed class action has been filed against a group of companies that manufacture and sell customized promotional items claiming they engaged in anticompetitive behavior and conspired to fix the prices of their products.

December 14, 2017 J&J and Janssen Biotech face more allegations the companies operated an 'exclusionary, competition-killing scheme' to maintain market control.

December 12, 2017 Allergan, Inc. is on the receiving end of a proposed class action lawsuit that accuses it of violating antitrust laws with respect to its prescription drug Restasis by attempting to 'extend its monopoly' over the market for cyclosporine emulsion eyedrops.

December 5, 2017 Three Mississippi hospitals claim the conduct of 19 pharma-industry heavyweights contributed greatly to the nation's opioid abuse epidemic.

November 21, 2017 Allergan, Inc. is facing a proposed class action lawsuit that claims it unlawfully attempted to block other companies from competing with it in the market for cyclosporine emulsion drugs.

November 17, 2017 German automakers Volkswagen, Audi, Porsche, Mercedes-Benz, and BMW are facing another lawsuit alleging they engaged in a series of 'covert meetings' to suppress competition and delay innovation, all while charging a premium price for their vehicles.

November 15, 2017 CDK Global, LLC and The Reynolds and Reynolds Company are facing a lawsuit that claims the defendants engaged in anticompetitive behavior by which they’ve systematically raised the prices of their products while eliminating competition.

November 15, 2017 An antitrust lawsuit alleges Johnson & Johnson and Janssen Biotech rigged the pricing for Remicade, a 'blockbuster' drug used to treat Crohn's Disease.

November 10, 2017 A class action says Pizza Hut is behind a no-hire, no-solicitation scheme that blocks franchisees from recruiting or hiring each other's managers.

November 7, 2017 Another proposed class action has been filed against Audi, BMW, Mercedes-Benz, Porsche, and Volkswagen – the 'German Five' – alleging the auto manufacturers engaged in an illegal scheme to suppress competition and raise the prices of their vehicles.

November 3, 2017 A suit filed in August aims to take on the 'German Auto Cartel' of five companies whose alleged anticompetitive practices have hurt the industry.

October 12, 2017 Five German automakers are once again facing a proposed class action alleging they engaged in anti-competitive behavior to suppress competition and raise prices of their vehicles.

October 9, 2017 Thirteen German automakers have been named as defendants in another proposed class action accusing them of engaging in 'a two decade-long conspiracy' to hinder technological innovation and the raise the prices of five German car brands.

October 6, 2017 Johnson & Johnson (J&J) and subsidiary Janssen Biotech, Inc. are facing a lawsuit alleging they engaged in an illegal antitrust scheme to raise prices of their infliximab drug and suppress competition.

September 29, 2017 A proposed class action case details an alleged two-decade-long conspiracy between German car makers to keep prices artificially inflated.

September 29, 2017 Major German car manufacturers find themselves as defendants in another antitrust class action lawsuit.

September 6, 2017 Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.

August 31, 2017 An Oregon woman has filed a proposed class action lawsuit against makers of customizable silicone wristbands and lanyards, alleging they violated Section 1 of the Sherman Antitrust Act by conspiring to fix product prices.

June 12, 2017 Independent eyecare providers claim in a class action that Davis Vision, Inc., HVHC, Inc., and Highmark Health violated federal antitrust laws.

June 1, 2017 Six more lawsuits have been added to a multidistrict litigation that claims various pharmaceutical companies have conspired to fix the price of generic drugs.

May 9, 2017 Four new complaints have been filed in PA federal court as part of a multidistrict litigation that claims various pharmaceutical companies conspired to fix drug prices.

April 25, 2017 Two Louisiana insurance companies have jointly filed two different lawsuits against pharmaceutical companies for allegedly conspiring to fix the prices of generic drugs.

April 20, 2017 A law firm and a Maine resident have filed a proposed class action against every county in Maine and their sheriffs, claiming the sheriffs have created a monopoly.

April 6, 2017 Another antitrust lawsuit has been filed against Mylan, its subsidiary, Sandoz, and Taro Pharmaceuticals USA Inc. claiming they conspired to fix generic drug prices.

April 5, 2017 Aurobindo Pharma USA, Inc., Citron Pharma LLC, Teva Pharmaceuticals USA, Inc., Heritage Pharmaceuticals, Inc. and two Heritage executives are the defendants in a lawsuit.

April 5, 2017 A proposed class action against several defendants claims they unlawfully conspired to fix the prices of generic Econazole Nitrate antifungal topical creams.

March 23, 2017 A lawsuit has been filed against nine pharmaceutical companies and their subsidiaries claiming the companies conspired to fix prices of generic pravastatin sodium.

March 22, 2017 1-800 Contacts, one of the biggest retailers for contact lenses sold online, is the defendant in another antitrust lawsuit, this time in Arkansas.

January 13, 2017 A proposed class action against the drug manufacturers listed below claims the entities unlawfully conspired to 'fix, maintain, and/or stabilize drug prices.

January 11, 2017 A New York state stock corporation is behind a proposed antitrust class action claiming four defendants engaged in an anti-competition conspiracy.

January 10, 2017 A proposed class action has been filed against Sanofi, U.S. and Sanofi GmbH claiming the companies violated federal antitrust laws.

January 3, 2017 The Detectives Endowment Association of the City of New York has filed a proposed class action in Pennsylvania against a collection of drug manufacturers.

December 30, 2016 A handful of pharmaceutical companies have been accused of fixing the prices of desonide topical creams and ointments.

December 13, 2016 Another antitrust lawsuit has been thrown at 1-800 Contacts alleging the company was the ringleader of a scheme that prevented contact lens companies from competing.

December 12, 2016 A proposed class action alleges a who's who of major pharmaceutical companies engaged in a conspiracy to fix the prices of certain generic drugs.

December 7, 2016 A proposed antitrust class action has been filed against a stable of pet food companies alleging they engaged in an anticompetitive conspiracy.

December 6, 2016 The price of pravastatin tablets was artificially inflated as the result of an alleged price-fixing conspiracy between a group of major drug companies.

November 21, 2016 Another class action has been filed claiming 1-800 Contacts has violated federal antitrust statutes by engaging in a conspiracy to illegally subdue competition.

November 17, 2016 Generic drug makers continue to be the subject of class action litigation alleging they illegally colluded to fraudulently inflate prices of essential drugs.

November 16, 2016 An antirust class action has been filed against a host of generic drug manufacturers claiming the companies illegally conspired to artificially inflate drug prices.

November 10, 2016 A class of independent pharmacies has filed an antitrust class action against several pharmaceutical companies over a price-fixing conspiracy.

November 3, 2016 An antitrust lawsuit has been filed against 1-800 Contacts, Inc. claiming the 'world's largest contacts lens store' artificially inflated the price of contacts.